Compensation for Cures: Why We Should Pay a Premium for Participation in ‘Challenge Studies’
6 Pages Posted: 30 Apr 2020
Date Written: September 2019
Abstract
Antibiotic resistance is one of the most pressing public health problems humanity faces. Research into new classes of antibiotics and new kinds of treatments – including risky experimental treatments such as phage therapy and vaccines – is an important part of improving our ability to treat infectious diseases. In order to aid this research, we will argue that we should permit researchers to pay people any amount of money to compensate for the risks of participating in clinical trials, including ‘challenge studies’ that involve deliberately infecting patients. We think that standard worries about paying for participation in risky research are reducible to concerns that can be addressed with the right screening mechanisms.
Keywords: antibiotic resistance, antibiotics, challenge studies, consent, phage therapy
Suggested Citation: Suggested Citation
Do you have a job opening that you would like to promote on SSRN?
Compensation for Cures: Why We Should Pay a Premium for Participation in ‘Challenge Studies’
This is a Wiley Blackwell - Medium Tier paper. Wiley Blackwell - Medium Tier charges $49.00 .
File name: BIOE.pdf
Size: 0K
If you wish to purchase the right to make copies of this paper for distribution to others, please select the quantity.
